Predictors, Risk Factors and Outcome Following Major Surgery (PROFS)
This is a multicentre, prospective, observational cohort study. Consecutive patients, operated in six University Hospitals in Sweden will be recruited following major surgical procedure. The length of patient recruitment period will be 12 weeks. The length of follow up will be 360 days . The objectives are to determine the postoperative morbidity (during the hospital stay), the survival (0-360 days), to identify risk factors for adverse outcomes and to identify risk factors that may potentially be influenced by any intervention in the future.
Amendments:
- The follow-up of mortality is extended to 3 years of the cohort
- The mortality of the background population at 30 and 90 Days will be analyzed
- Validation of the Surgical Outcome Risk Tool in the study cohort and in the background population are planned
研究概览
详细说明
This is a multicenter, prospective, observational study. Length of patient recruitment is 12 weeks, the length of observation is 360 postoperative days. The expected number of patients is 1000.
Patients will be selected from the operation planning software on each study site. It is done by daily screening of the operation list and will be enrolled by applying the inclusion criteria. The criteria of surgical severity will be assessed by the UK surgical severity grading system ( AXA PPP/ Specialist Procedure Codes, United Kingdom). For that purpose a scroll list will be used, which is available on the website of the Surgical Outcome Risk Tool calculator.
Patient characteristics will be prospectively collected from medical records: age, gender, co-morbidities, medical history, physical activity, blood pressure, heart rate, oxygen saturation and neurological function; routine laboratory findings; type, complexity, urgency of surgery, incision localization and malignancy; lowest intraoperative systolic blood pressure, heart rate. The outcomes are the postoperative morbidity (assessed by the Postoperative Morbidity Survey) classified by the Clavien-Dindo classification tool (during hospital stay), and mortality, use of medications, hospital re-admissions (0-360 days) and new occurrence in different disease related national quality registries.Relationships between postoperative morbidity (POMS) the severity of morbidity (Clavien Dindo) and mortality will be analyzed. For illustration, Kaplan Meyer plots will be used, and for analyses Cox proportional hazard model will be used with adjustment for sex and age.
Additional changes:
- The length of observation for survival was extended to 3 years. The mortality at 3 years will be analyzed addressing the relationship between the postoperative morbidity (POMS) and mortality. Cox regression model will be used with adjustment of age, comorbidity and malignancy.
- Validation of Surgical Outcome Risk Tool is planned in two populations related to the PROFS study: eligible and background population. As the PROFS cohort was manually selected, we presumed that the eligible population is larger than the enrolled population.To enable electronic selection of the eligible population, we have developed a script, which translates the Swedish surgical codes into the UK severity codes. Using the same script we will classify the surgical severity in the background population of the PROFS cohort. Variables included in the Surgical Outcome Risk Tool will be extracted from the operation databases of each study site. The date of death will be extracted from the Swedish National Adress Registry and the malignancy from the registry of National Swedish Cancer Registry.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Huddinge、瑞典、14186
- Karolinska University Hospital
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Eligibility Criteria:
Sex: male or female Age limits: minimum age 18 Years maximum age: no limits
Inclusion criteria:
- individuals classified by the American Society of Anesthesiologists Physical Status Classification System (ASA) ≥ 3 AND
- are scheduled for elective or emergency surgical procedure classified as -major OR major/complex by Surgical Outcome Risk Tool (SORT)
Non eligibility criteria are the following surgical procedures:
- organ transplantation
- immediate trauma
- breast
- ear, nose throat
- central nervous system
- cardiac, vascular, pulmonary,
- face, mouth, salivary, thyroidea
- skin, subcutaneous tissue
- endoscopic gastrointestinal
- lack of Swedish identity number
Exclusion Criteria:
- patients who refuse the follow up
- patients who are not available for the follow up (living in other countries)
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
---|---|
Major surgical procedures
All patients selected to follow up
|
observation of postoperative outcomes
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
postoperative complications
大体时间:3-10 postoperative days
|
postoperative morbidity survey, Clavien Dindo
|
3-10 postoperative days
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
postoperative mortality
大体时间:30-360 postoperative days and 3 years
|
number of deaths at 30, 360 Days AND 3 years
|
30-360 postoperative days and 3 years
|
合作者和调查者
合作者
调查人员
- 首席研究员:Sigriduar Kalman, MD PhD、Karolinska Institutet
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
Major surgical procedure的临床试验
-
Tehran University of Medical SciencesPasteur Institute of Iran, Tehran, Iran; Razi Vaccine and Serum Research Institute; Centre for...完全的
-
Tehran University of Medical SciencesPasteur Institute of Iran, Tehran, Iran; Razi Vaccine and Serum Research Institute; Centre for...完全的